Advertisement

Topics

Therapure Biopharma Inc. Announces Spin Off and Sale of Contract Development and Manufacturing Business for US$290 Million

07:57 EDT 4 Sep 2017 | Biotech-Finances

Sunday, September 3rd 2017 at 11:11am UTC CDMO Purchase by Joint Venture Between 3SBio Inc. and CPE Funds Further Strengthens Biomanufacturing Growth Opportunities The Catalyst Capital Group Inc. to Retain and Focus on Commercialization of Plasma Products Under Separate Entity MISSISSAUGA, Ontario–(BUSINESS WIRE)– Therapure Biopharma Inc. (“Therapure” or the “Company”) today announced that a joint …

Cet article Therapure Biopharma Inc. Announces Spin Off and Sale of Contract
Development and Manufacturing Business for US$290 Million
est apparu en premier sur EEI-BIOTECHFINANCES.

Original Article: Therapure Biopharma Inc. Announces Spin Off and Sale of Contract Development and Manufacturing Business for US$290 Million

NEXT ARTICLE

More From BioPortfolio on "Therapure Biopharma Inc. Announces Spin Off and Sale of Contract Development and Manufacturing Business for US$290 Million"

Quick Search
Advertisement
 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...